HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 1, 1996, Pages 84-92

  De Carvalho, Heráclito Barbosa ^a,b   Mesquita, Fábio ^a,b   Massad, Eduardo ^a,b   Bueno, Regina Carvalho ^b   Lopes, Giselda Turienzo ^b,c   Ruiz, Milton Arthur ^a,b   Burattini, Marcelo Nascimento ^a,b,d,e  

^a NUPAIDS   (Brazil)

^b IEPAS   (Brazil)

^c Secretaria de Estado da Saude   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Cocaine; Hepatitis B; Hepatitis C; HIV; HTLV (1 and 2); Injecting drug users; Syphilis

Indexed keywords

ARTICLE; BRAZIL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HTLV; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029867355     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199605010-00012     Document Type: Article

References (31)

1. WHO collaborative study group on drug abuse, programme on substance abuse: multi-city study of HIV infection among IDUs. In: Final Report of the WHO/PSA. 1994 (in press).
2. Des Jarlais DC, Friedman SR. Critical issues regarding AIDS among injecting drug users. Bull Narc 1993;45:61-75.
3. Des Jarlais DC, Friedman RS. AIDS and the use of injected drugs. Sci Am 1994;270:56-62.
4. Stimson GV. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. Bull Narc 1993;45:3-17.
5. Long S. China unprepared for growth in AIDS from drug abuse. Guardian 1990 Mar 5.
6. Sarkar S, Panda S, Naik TN, et al. Rapid spread of HIV among injecting drug users in north-eastern states of India. Bull Narc 1993;45:91-105.
7. Poshyachinda V. Drug injecting and HIV infection among the population of drug users in Asia. Bull Narc 1993;45:77-90.
8. Mesquita F. Em tempos de AIDS: AIDS e drogas. São Paulo: Summus, 1992.
9. World Health Organization (WHO). WHO collaborative study group on drug abuse: an international comparative study of HIV prevalence and risk behavior among drug injectors in 13 cities. Bull Narc 1993;45:19-46.
10. Epidemiological bulletin 2. São Paulo: Secretariat of Health of the City of Santos, April 1984.
11. Epidemiological bulletin 14. São Paulo: Secretariat of Health of the City of Santos, July 1994.
12. Epidemiological bulletin 8. São Paulo: National Program of Control of STD/AIDS of Ministry of Health of Brazil, August 1994.
13. Dean AD, Dean JA, Burton JH, Dicker RC. Epiinfo version 5: a word processing, data base, and statistics program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control, 1990.
14. Massad E, Coutinho FAB, Yang HM, Carvalho HB, Mesquita F, Burattini MN. The basic reproduction ratio of HIV among intravenous drug users. Math Biosci 1994;123:227-47.
15. Blower SN, McLean AR. Prophilactic vaccines, risk behavior change and the probability of eradicating HIV in San Francisco. Science 1994;265:1451-4.
16. Andrade ALSS, Martelli CMT, et al. Rastreamento sorológico para doenças infecciosas em banco de sangue como indicador de morbidade populacional. Rev Saude Publica 1989;23:20-5.
17. Vaz AJ, Guerra EM, Ferratto LCC, Toledo LAS, Neto RSA. Sorologia positiva para sífilis, toxoplasmose e doença de Chagas em gestantes de primeira consulta em centros de saúde de área metropolitana, Brasil. Rev Saude Publica 1990;24:373-9.
18. Wilcox RR, Guthe T. Treponema pallidum: a bibliographical review of the morphology, culture and survival of Treponema pallidum and associated organisms. Bull World Health Organ 1966;35(suppl):1.
19. Tramont EC. Treponema pallidum. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:1794-808.
20. Mann J, Tarantola DJM, Netter TW. AIDS in the world. Boston: Harvard University Press, 1992.
21. Lima ES, Friedman SR, Bastos FI, et al. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. Addiction 1994;89:689-98.
22. Longo MA, Noto P, Tossini G, et al. First demonstration of the main transmission routes for HCV infection in Italy [Abstract 1353]. In: Sixth International Congress for Infectious Diseases, Prague, Czech Republic April 26-30; vol 1. 1994:414.
23. Hsu HH, Gonzales M, Foung SKH, et al. Antibodies to hepatitis C virus in low-risk blood donors: implications for counselling positive donors. Gastroenterology 1991;101: 1724-7.
24. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
25. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
26. Roggendorf M, Deinhardt F, Rasshofer R, et al. Antibodies to hepatitis C virus. Lancet 1989;2:324-5.
27. Dawson GJ, Lesniewski RR, Stewart JL, et al. Detection of antibodies to hepatitis C virus in US blood donors. J Clin Microbiol 1991;29:551-6.
28. Follett EAC, Dow BC, McOmish F. HCV confirmatory testing of blood donors. Lancet 1991;338:1024.
29. Esteban JI, Camps J, Genesca J, Alter JH. Hepatitis C and B: new developments. In: Nance SJ, ed. Blood safety current challenges. Bethesda, MD: American Association of Blood Banks, 1992:45-96.
30. Lima VCP, Chiattoni CS, Burattini MN, et al. Seroprevalence study of hepatitis C virus antibody and HIV 1 infection among volunteer blood donors, S. Paulo, Brazil [Abstract C355]. In: Eighth International Conference on AIDS, Amsterdam, July 1992.
31. Vanderborght BOM, Reis AMM, Rouzer CD, et al. Prevalence of anti-hepatitis C virus in the blood donor population of Rio de Janeiro. Vox Sang 1993;65:122-5.